Connection

John Su to United States

Back to Details
This is a "connection" page, showing publications John Su has written about United States.
John Su
Connection Strength
0.165
United States
  1. Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021. JAMA. 2021 Mar 16; 325(11):1101-1102.
    View in: PubMed
    Score: 0.032
  2. Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016. J Allergy Clin Immunol. 2019 04; 143(4):1465-1473.
    View in: PubMed
    Score: 0.028
  3. Do women with persistently negative nontreponemal test results transmit syphilis during pregnancy? Sex Transm Dis. 2013 Apr; 40(4):311-5.
    View in: PubMed
    Score: 0.019
  4. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 13; 70(32):1094-1099.
    View in: PubMed
    Score: 0.008
  5. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 06; 70(31):1053-1058.
    View in: PubMed
    Score: 0.008
  6. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 09; 70(27):977-982.
    View in: PubMed
    Score: 0.008
  7. U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine. 2021 06 23; 39(28):3666-3677.
    View in: PubMed
    Score: 0.008
  8. Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021. MMWR Morb Mortal Wkly Rep. 2021 May 07; 70(18):685-688.
    View in: PubMed
    Score: 0.008
  9. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021 May 07; 70(18):680-684.
    View in: PubMed
    Score: 0.008
  10. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 30; 70(17):651-656.
    View in: PubMed
    Score: 0.008
  11. First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021 Feb 26; 70(8):283-288.
    View in: PubMed
    Score: 0.008
  12. Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018. MMWR Morb Mortal Wkly Rep. 2019 Feb 01; 68(4):91-94.
    View in: PubMed
    Score: 0.007
  13. Reported Primary and Secondary Syphilis Cases in the United States: Implications for HIV Infection. Sex Transm Dis. 2018 09; 45(9S Suppl 1):S42-S47.
    View in: PubMed
    Score: 0.007
  14. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Hum Vaccin Immunother. 2018; 14(8):1963-1969.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.